Sell AbbVie Stock Ahead of Its Upcoming Earnings?

1. AbbVie reports earnings on July 31, 2025, with expected $2.91 EPS. 2. Historically, ABBV has negative returns post-earnings 65% of the time. 3. The median drop is -1.3%, with a maximum decline of -7.3%. 4. Only 35% of post-earnings returns were positive in five years. 5. Current market cap is $333 billion, generating $57 billion in revenue.